Affimed N.V. - Common Stock (NQ:AFMD)

0.1815 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Affimed N.V. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Which stocks are experiencing notable movement on Monday? ↗

May 19, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Top stock movements in today's session. ↗

May 19, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Gapping stocks in Monday's session ↗

May 19, 2025

Let's have a look at what is happening on the US markets on Monday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Dow Tumbles 200 Points; ZIM Integrated Shipping Services Posts Upbeat Earnings ↗

May 19, 2025

Via Benzinga

Topics Stocks

These stocks are moving in today's pre-market session ↗

May 19, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2025

Via Benzinga

What's going on in today's after hours session ↗

May 16, 2025

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Friday's session: most active stocks ↗

May 16, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the most active stocks in today's session.

Via Chartmill

US Stocks Edge Higher; Consumer Sentiment Falls In May ↗

May 16, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

May 15, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 15, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top movers in Thursday's pre-market session ↗

May 15, 2025

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Wednesday's pre-market session: top gainers and losers ↗

May 14, 2025

Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Affimed Announces Receipt of Nasdaq Delisting Notice

May 14, 2025

From Affimed N.V.

Via GlobeNewswire

These stocks are moving in today's session ↗

May 13, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

Crude Oil Gains 3%; US Inflation Eases In April ↗

May 13, 2025

Via Benzinga

Topics Economy

Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales ↗

May 13, 2025

Via Benzinga

This Caterpillar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

May 13, 2025

Via Benzinga

Affimed Announces Filing for the Opening of Insolvency Proceedings

May 13, 2025

From Affimed N.V.

Via GlobeNewswire

This Rapid7 Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday ↗

May 13, 2025

Via Benzinga

Stanley Black & Decker To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

May 13, 2025

Via Benzinga

Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting

April 29, 2025

From Affimed N.V.

Via GlobeNewswire

Affimed Announces Acceptance of Three Abstracts for Presentation at the American Society for Clinical Oncology Annual Meeting

April 23, 2025

From Affimed N.V.

Via GlobeNewswire

Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode ↗

April 21, 2025

The company has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance with Nasdaq’s Minimum Bid Price Rule.

Via Stocktwits

Topics World Trade

Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

April 21, 2025

From Affimed N.V.

Via GlobeNewswire

Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting

March 25, 2025

From Affimed N.V.

Via GlobeNewswire

Affimed to Present at the Leerink Partners Global Healthcare Conference 2025

March 03, 2025

From Affimed N.V.

Via GlobeNewswire

Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)

December 17, 2024

From Affimed N.V.

Via GlobeNewswire

Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

December 09, 2024

From Affimed N.V.

Via GlobeNewswire

Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer

December 09, 2024

From Affimed N.V.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.